Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

PURPOSE: Patients with advanced pancreas cancer present with disease that is poorly responsive to conventional therapies. Preclinical and early clinical evidence has supported targeting the epidermal growth factor receptor (EGFR) signaling pathway in patients with pancreas cancer. This trial was con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Philip, Philip A., Benedetti, Jacqueline, Corless, Christopher L., Wong, Ralph, O'Reilly, Eileen M., Flynn, Patrick J., Rowland, Kendrith M., Atkins, James N., Mirtsching, Barry C., Rivkin, Saul E., Khorana, Alok A., Goldman, Bryan, Fenoglio-Preiser, Cecilia M., Abbruzzese, James L., Blanke, Charles D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2010
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917315/
https://ncbi.nlm.nih.gov/pubmed/20606093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.7550
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak